Middle East and Africa Point-of-Care Diagnostics Market, By Type (Devices, Consumables and Kits, Software and Services, Accessories), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Pharmacies), Country (South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait, Mauritius, Qatar, Oman, Iraq, Bahrain, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Middle East and Africa Point-of-Care Diagnostics Market
Middle East and Africa point-of-care diagnostics market is expected to reach USD 2,064.86 million by 2028, growing with a CAGR of 6.1% in the forecast period of 2021 to 2028. Increasing prevalence of chronic diseases and rising preference for homecare testing is anticipated to drive the growth of the market.
Point-of-care diagnostics is characterized as testing which can be done in close proximity to the patient where a medical decision can be made immediately, including the results and monitoring. Point-of-care diagnostics is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes as compared to hours. It ensures patients receive the most effective and efficient care when and wherever needed. Additionally, point-of-care diagnostics enables staff to make rapid decisions of treatments when diagnosing patients’ conditions and the point-of-care diagnostics simplifying the testing process.
The major factors driving the point-of-care diagnostics market's growth are the increasing number of liver, kidney diseases and emerging technologies of point-of-care diagnostics. The factor that affects the point-of-care diagnostics market from growing is the high cost of equipment and stringent government regulations.
The point-of-care diagnostics market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa Point-of-Care Diagnostics Market Scope and Market Size
Point-of-care diagnostics market is segmented into four notable segments which are based on the type, platform, end user and distribution channel. The growth amongst these segments will help you analyze growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the point-of-care diagnostics market is segmented into devices, software and services, consumables and kits, and accessories. In 2021, the devices segment in point-of-care diagnostics market is expected to grow due to changing lifestyle and increasing chronic diseases and lack of awareness on over-the-counter point-of-care diagnostics devices.
- On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics, immunoassays. In 2021, the lateral flow assays/immunochromatography tests segment in the point-of-care diagnostics market is expected to grow due to advanced technologies and inventions.
- On the basis of end-user, the point-of-care diagnostics market is segmented into professional diagnostic centers, home care, research laboratories and other end users. In 2021, the professional diagnostic centers segment in the point-of-care diagnostics market is expected to grow due to growing patient emphasis on diagnosis operations. However, the high investment cost may hamper the point-of-care diagnostics market growth.
- On the basis of distribution channel, the point-of-care diagnostics market is segmented into direct tender and retail sales. In 2021, the distribution channel segment in point-of-care diagnostics market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical cares for operations and diagnosis.
Point-of-Care Diagnostics Market Country Level Analysis
The point-of-care diagnostics market is analysed and market size information is provided by type, platform, end user, distribution channel as referenced above.
The countries covered in Middle East and Africa point-of-care diagnostics market are South Africa, UAE, Bahrain, Saudi Arabia, Egypt, Israel, Kuwait, Mauritius, Qatar, Oman, Iraq, Rest of Middle East and Africa.
South Africa is dominating the point-of-care diagnostics market due to the largest market share of the manufacturers present in South Africa and the increasing diagnostic rate in South Africa. Saudi Arabia is dominating due to growing popularity of wearable or portable glucose monitoring devices. UAE is dominating due to improving diagnosis seeking rate and growing popularity of wearable or portable glucose monitoring devices.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufactures is Creating New Opportunities for Players in the Point-of-Care Diagnostics Market
Point-of-care diagnostics market also provides you with detailed market analysis for every country growth in aesthetic industry with point-of-care diagnostics market sales, impact of advancement in the point-of-care diagnostics market and changes in regulatory scenarios with their support for the Point-of-care diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point-of-Care Diagnostics Market Share Analysis
Point-of-care diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to point-of-care diagnostics market.
Some of the prominent participants operating in the Middle East and Africa point-of-care diagnostics market are BioTech Africa, Medtronic, Bio-Rad Laboratories, Inc., PTS Diagnostics, Trinity Biotech, Atlas Medical Uk, Abbott, Sysmex Corporation, bioMérieux SA, Quidel Corporation, BD, Sekisui Diagnostics, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., ACON Laboratories, Inc., Nova Biomedical, Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG), and Instrumentation Laboratory among other domestic and MEA players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the point-of-care diagnostics market.
For instance,
- In August 2020, Siemens Healthcare Private Limited has announced that they have agreed to the acquisition of the company named Varian to enhance the fight against cancer and for strengthening their business in the healthcare sector. It will help the company in the enhancement of its credibility in the market.
- In September 2020, Instrumentation Laboratory received clearance from Food and Drug Administration (FDA) for its HemosIL Liquid Anti-Xa test kit for its de novo marketing. This test is also the first direct, oral anti-coagulant test to carry out automated homeostasis. This will help in the growth of the market in coming years.
Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the point-of-care diagnostics market which also provides the benefit for organisation to improve their offering for point-of-care diagnostics market.
SKU-
